Summary of Use during Lactation

No information is available on the clinical use of lumateperone during breastfeeding. Because lumateperone is 97.5% bound to plasma proteins, the amount in milk is likely to be low. However, the manufacturer recommends that breastfeeding be discontinued during lumateperone therapy. Until more safety data become available, an alternate drug may be preferred.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Antipsychotic) Haloperidol, Olanzapine, Risperidone, Quetiapine (Bipolar Disorder) Divalproex, Lithium, Olanzapine, Quetiapine, Risperidone, Valproic Acid

Substance Name

Lumateperone

CAS Registry Number

313368-91-1

Drug Class

Breast Feeding

Lactation

Milk, Human

Antipsychotic Agents